• Company
    • Vision & Mission
    • History & Milestones
    • Leadership
      • Founder's Profile
      • Management team
    • Chairman's Message
    • Accolades
    • EH&S
    • Quality Control
  • Research
    • Patents
    • Publications
    • Manufacturing Facilities
    • R&D Pipeline
    • Clinical Research
    • Research Areas
    • Partnerships
    • Exports
  • Products
    • Vaccines
      • Biohib®
      • Biopolio®
      • ComvacTM 3
      • Comvac 4®
      • Comvac 5®
      • COVAXIN®
      • Hillchol®
      • HNVAC®
      • iNCOVACC®
      • Indirab®
      • JENVAC®
      • Revac-B mcf®
      • Revac-B®+
      • ROTAVAC®
      • ROTAVAC 5D®
      • Typbar®
      • Typbar TCV®
    • Therapeutics
      • SLVRGEN®
      • Biogit®
      • Regen-D® 150
      • Regen-D® 60
      • Zelect®
  • Corporate Governance
    • Other Resources
    • CSR Policy
    • Nomination and Remuneration Policy
    • POSH Policy
    • Vigil Mechanism
    • Announcements & Notices
  • Careers
    • HR Philosophy
    • Apply
    • Work @ Bharat Biotech
  • Media
    • Announcements
    • Bharat in News
    • Gallery
    • Corporate Profile
    • Press Releases
  • Contact
    • Route map
  • Home /
  • Media /
  • Media in Library/
  • Announcements
  • Announcements
  • Bharat in News
  • Corporate Profile
  • Gallery
  • Press Releases

Announcements

Browse through our official announcements.

  • 2024
  • 2023
  • May 02: COVAXIN® - Safety First - Issued in Public Interest

    June 16: Rotavac: Bharat Biotech Fact Check in Public Interest

    Aug 07: The Supreme Court of India Dismisses Public Interest Litigation on Rotavirus Vaccine

    Sept 04: BBIL Contributes to Chief Minister's Relief Fund Telangana

    Sept 04: BBIL Contributes to Chief Minister's Relief Fund Andhra Pradesh

    Sept 11: Bharat Biotech Announces Collaboration with Alopexx for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328

    Sept 28: Bharat Biotech Collaborates with CII to Restore Historic Stepwells in Telangana

  • Jan 23: Voluntary Product Recall notification for ChiroRab® Vaccine

+ -

Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities. Our mission is to deliver affordable, safe and high-quality vaccines and bio-therapeutics that help people prevail over diseases. We seek to lead innovation in biotechnology in order to lead the fight against disease with a focus on emerging markets.


Quick Links
  • Overview
  • History & Milestones
  • Founder's Profile
  • Accolades
  • Quality Control
  • Publications
  • Clinical Research
  • Manufacturing Facilities
  • Partnerships
  • HR Philosophy
  • Media Library
  • Bharat in News
  • Press Releases
  • Research Areas
  • R&D Pipeline
  • Patents
  • EH&S
  • Contact Us

Our Products
  • Biohib
  • Biogit
  • Biopolio
  • Comvac 3
  • Comvac 4
  • Comvac 5
  • Hillchol
  • HNVAC
  • Indirab
  • iNCOVACC
  • JENVAC
  • Revac-B mcf
  • Revac-B+
  • Regen-D 150
  • Regen-D 60
  • ROTAVAC
  • ROTAVAC 5D
  • SLVRGEN
  • Typbar
  • Typbar TCV

© 2022 Bharat Biotech. All Rights Reserved.

  • Privacy Policy   |
  • Terms of Service